Version 5.4
Mus musculus Protein: Apobec1
Summary
InnateDB Protein IDBP-534300.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Apobec1
Protein Name apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
Synonyms Cdar1;
Species Mus musculus
Ensembl Protein ENSMUSP00000116238
InnateDB Gene IDBG-185598 (Apobec1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Experimentally validated
Total 2 [view]
Protein-Protein 1 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 1 [view]
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 5 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0017091 AU-rich element binding
Biological Process
GO:0010332 response to gamma radiation
GO:0016554 cytidine to uridine editing
GO:0016556 mRNA modification
GO:0042127 regulation of cell proliferation
GO:0042157 lipoprotein metabolic process
GO:0042158 lipoprotein biosynthetic process
GO:0042953 lipoprotein transport
GO:0048255 mRNA stabilization
Cellular Component
Protein Structure and Domains
PDB ID MGI:103298
InterPro
PFAM
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL D3Z675
UniProt Splice Variant
Entrez Gene 11810
UniGene Mm.401410
RefSeq
MGI ID
MGI Symbol Apobec1
OMIM
CCDS
HPRD
IMGT
EMBL AC158651
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca